Medicis Pharmaceutical — Inamed — Merger or Acquisition (March 2005)
10 slides from Medicis Pharmaceutical's merger presentation, Mar 24, 2005
Slide 1: Medicis and Inamed: creating opportunities together
Slide 2: Our Aspirations
Our Aspirations Partner of choice for our customers Expanded product portfolio Customer centric focus Patient choice for enhancement of their overall health, beauty and self-esteem Innovative R&D pipeline New, distinct culture, preserving values at the core of each company's success
Slide 3: The Medicis Story
The Medicis Story Founded 1988 IPO - April 1990 4 stock splits since 1996 NYSE - September 1998 Why the dermatology market? Exceeds $5 billion Driven by 3,200 dermatologists Favorable demographics Evolved with market to aesthetic procedures
Slide 4: Mission Statement
Mission Statement .. . . helping patients attain a healthy and youthful appearance and self-image
Slide 5: Four-Part Growth Strategy
Four-Part Growth Strategy Core brand growth Product development Collaborative relationships Strategic acquisitions
Slide 6: Stronger Growth-Oriented Company
Stronger Growth-Oriented Company Complementary products Enhanced global presence Approximately 1,500 employees Operations in 12 countries Business in over 60 countries Enhanced R&D World class customer service and business support functions Opportunities for advancement within a growing company
Slide 7: Integration Principles (1/2)
Integration Principles (1/2) Our people are our greatest asset Maintain performance and customer relationships Exercise fiscal responsibility Build best new business model Integration to maximize value Joint task forces to address integration issues
Slide 8: Integration Principles (2/2)
Great talent from every part of the organization needed to maximize opportunities Move quickly to operate as one business on day merger occurs: One management team One operating plan Business as usual until then Integration Principles (2/2)
Slide 9: Closing Remarks
Closing Remarks MELCISN <D
Slide 10: Forward-Looking Statements
FORWARD-LOOKING STATEMENTS This document contains “forward-looking statements” within the meaning of the Securities Litigation Reform Act. All statements included herein that address activities, events or developments that Medicis and Inamed expect, believe or anticipate will or may occur in the fut